MDR compliance translation
The EU MDR makes accurate local-language documentation a legal condition of CE certification. We translate technical files that pass notified-body review the first time.
What the MDR actually mandates
The EU Medical Device Regulation (EU MDR 2017/745) makes language a condition of market access. Your instructions for use, labeling and packaging must be provided in the official language of every member state where the device is sold — the member state decides which language, not the manufacturer. The EU has 24 official languages across 27 member states; a device distributed in Germany, France, Spain, Italy and Poland needs compliant documentation in all five languages as a minimum.
The regulation also sets a quality bar. Documentation must be “easily understood by the intended user” — a standard that covers readability, correct clinical terminology and consistency with the labeling your notified body already reviewed. Machine-translated or generalist-translated IFUs routinely fail it, and a notified body — the auditor that certifies your device for the EU market — can reject translations that fall short, no matter how long the product has been on the market.
The deadlines that make this urgent
From May 26, 2026, EUDAMED — the EU central database covering device registration, UDI, certificates, vigilance and market surveillance — becomes fully mandatory. Device records must link to compliant documentation, which means every IFU in your portfolio needs a current, validated translation for every market where the device is registered. Manufacturers who leave translation as a final-stage task consistently find it is the item that blows the timeline: a full EU portfolio can mean 15 to 20 language versions per device family, each needing specialist translation and expert review.
What survives notified-body scrutiny
Notified bodies increasingly audit the translation process, not just the output. Since 2005, Link Translation has built medical translation around the elements they expect to see:
- Specialist translators — native-language linguists from our health-science practice group, with medical or life-science backgrounds matched to your device category
- A controlled term base — the same clinical term rendered identically across IFU, labeling, software and clinical files; terminology drift is one of the most common audit findings
- Independent second review — every file checked against the source by a second qualified specialist, producing a documented quality record
- Version control via translation memory — when the source IFU changes, every language version is updated on the delta, so your language portfolio never falls out of sync
- Traceability — each target file maps segment-by-segment to the source, which slots directly into your document control
Priorities if you are behind
Start with an inventory: every document, mapped against every market where the device is distributed, flagged where a current expert-reviewed translation is missing. Prioritize by risk class — Class IIa, IIb and III devices face the toughest technical-file scrutiny — and by market exposure. Then put a standing update protocol in your quality system so that a source revision automatically triggers translation updates in all languages. We support all three steps, starting with a fixed quote on your full language scope within 24 hours.
Frequently asked questions
What exactly does the MDR require me to translate?
The instructions for use, device labeling and packaging text must be provided in the official language(s) of each member state where the device is made available. For Class III and implantable devices, the SSCP must be publicly available in all EU official languages. Notified bodies can also request translated sections of the technical file.
Is there an exception for professional-use devices?
A narrow one. Where the intended user is a trained healthcare professional, some member states accept an IFU in a language that professional community broadly understands. It requires documented justification, and you should confirm it with your notified body rather than assume it applies.
What is the EUDAMED deadline?
EUDAMED, the EU central medical device database, becomes fully mandatory on May 26, 2026. From that date, device registration, UDI management and post-market reporting run through it — and device records must link to documentation that meets the MDR language requirements.
What do notified bodies look for in translations?
Evidence of a structured, auditable process — not just a finished document. That means qualified specialist translators, an independent second review, consistent terminology across the documentation set, and version control that keeps every language in sync with the current source.